Maven Securities LTD Rocket Pharmaceuticals, Inc. Transaction History

Maven Securities LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $4.66 Million - $8.32 Million	-170,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $203,592 - $244,093	5,166 Added 3.13%	170,000 $7.5 Million
Q1 2021 May 17, 2021	BUY	$43.34 - $65.91 $2.81 Million - $4.27 Million	64,834 Added 64.83%	164,834 $7.31 Million
Q4 2020 Feb 12, 2021	BUY	$23.3 - $59.57 $2.33 Million - $5.96 Million	100,000 New	100,000 $5.62 Million
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $301,010 - $778,410	-31,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $343,170 - $751,130	31,000 New	31,000 $729,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.